229 related articles for article (PubMed ID: 35002625)
21. Medicinal chemistry, pharmacology, and therapeutic potential of α-conotoxins antagonizing the α9α10 nicotinic acetylcholine receptor.
Li X; Tae HS; Chu Y; Jiang T; Adams DJ; Yu R
Pharmacol Ther; 2021 Jun; 222():107792. PubMed ID: 33309557
[TBL] [Abstract][Full Text] [Related]
22. α-Conotoxin Vc1.1 Structure-Activity Relationship at the Human α9α10 Nicotinic Acetylcholine Receptor Investigated by Minimal Side Chain Replacement.
Chu X; Tae HS; Xu Q; Jiang T; Adams DJ; Yu R
ACS Chem Neurosci; 2019 Oct; 10(10):4328-4336. PubMed ID: 31411453
[TBL] [Abstract][Full Text] [Related]
23. A novel fluorescent alpha-conotoxin for the study of alpha7 nicotinic acetylcholine receptors.
Hone AJ; Whiteaker P; Christensen S; Xiao Y; Meyer EL; McIntosh JM
J Neurochem; 2009 Oct; 111(1):80-9. PubMed ID: 19650873
[TBL] [Abstract][Full Text] [Related]
24. Critical residue properties for potency and selectivity of α-Conotoxin RgIA towards α9α10 nicotinic acetylcholine receptors.
Huynh PN; Harvey PJ; Gajewiak J; Craik DJ; Michael McIntosh J
Biochem Pharmacol; 2020 Nov; 181():114124. PubMed ID: 32593612
[TBL] [Abstract][Full Text] [Related]
25. Identification of a Novel O-Conotoxin Reveals an Unusual and Potent Inhibitor of the Human α9α10 Nicotinic Acetylcholine Receptor.
Jiang S; Tae HS; Xu S; Shao X; Adams DJ; Wang C
Mar Drugs; 2017 Jun; 15(6):. PubMed ID: 28598389
[TBL] [Abstract][Full Text] [Related]
26. Dimerization of α-Conotoxins as a Strategy to Enhance the Inhibition of the Human α7 and α9α10 Nicotinic Acetylcholine Receptors.
Liang J; Tae HS; Xu X; Jiang T; Adams DJ; Yu R
J Med Chem; 2020 Mar; 63(6):2974-2985. PubMed ID: 32101438
[TBL] [Abstract][Full Text] [Related]
27. Oligoarginine Peptides, a New Family of Nicotinic Acetylcholine Receptor Inhibitors.
Lebedev DS; Kryukova EV; Ivanov IA; Egorova NS; Timofeev ND; Spirova EN; Tufanova EY; Siniavin AE; Kudryavtsev DS; Kasheverov IE; Zouridakis M; Katsarava R; Zavradashvili N; Iagorshvili I; Tzartos SJ; Tsetlin VI
Mol Pharmacol; 2019 Nov; 96(5):664-673. PubMed ID: 31492697
[TBL] [Abstract][Full Text] [Related]
28. Crystal Structure of the Monomeric Extracellular Domain of α9 Nicotinic Receptor Subunit in Complex With α-Conotoxin RgIA: Molecular Dynamics Insights Into RgIA Binding to α9α10 Nicotinic Receptors.
Zouridakis M; Papakyriakou A; Ivanov IA; Kasheverov IE; Tsetlin V; Tzartos S; Giastas P
Front Pharmacol; 2019; 10():474. PubMed ID: 31118896
[TBL] [Abstract][Full Text] [Related]
29. The α9α10 nicotinic acetylcholine receptors antagonist α-conotoxin RgIA reverses colitis signs in murine dextran sodium sulfate model.
AlSharari SD; Toma W; Mahmood HM; Michael McIntosh J; Imad Damaj M
Eur J Pharmacol; 2020 Sep; 883():173320. PubMed ID: 32645334
[TBL] [Abstract][Full Text] [Related]
30. A novel mechanism of inhibition of high-voltage activated calcium channels by α-conotoxins contributes to relief of nerve injury-induced neuropathic pain.
Klimis H; Adams DJ; Callaghan B; Nevin S; Alewood PF; Vaughan CW; Mozar CA; Christie MJ
Pain; 2011 Feb; 152(2):259-266. PubMed ID: 20889259
[TBL] [Abstract][Full Text] [Related]
31. d-Amino Acid Substitution of α-Conotoxin RgIA Identifies its Critical Residues and Improves the Enzymatic Stability.
Ren J; Zhu X; Xu P; Li R; Fu Y; Dong S; Zhangsun D; Wu Y; Luo S
Mar Drugs; 2019 Feb; 17(3):. PubMed ID: 30823399
[TBL] [Abstract][Full Text] [Related]
32. Alkaloid ligands enable function of homomeric human α10 nicotinic acetylcholine receptors.
Hone AJ; McIntosh JM
Front Pharmacol; 2022; 13():981760. PubMed ID: 36188578
[TBL] [Abstract][Full Text] [Related]
33. The human alpha7 nicotinic acetylcholine receptor is a host target for the rabies virus glycoprotein.
O'Brien BCV; Thao S; Weber L; Danielson HL; Boldt AD; Hueffer K; Weltzin MM
Front Cell Infect Microbiol; 2024; 14():1394713. PubMed ID: 38836054
[TBL] [Abstract][Full Text] [Related]
34. Differential involvement of α4β2, α7 and α9α10 nicotinic acetylcholine receptors in B lymphocyte activation in vitro.
Koval L; Lykhmus O; Zhmak M; Khruschov A; Tsetlin V; Magrini E; Viola A; Chernyavsky A; Qian J; Grando S; Komisarenko S; Skok M
Int J Biochem Cell Biol; 2011 Apr; 43(4):516-24. PubMed ID: 21146628
[TBL] [Abstract][Full Text] [Related]
35. Structure-Activity Studies Reveal the Molecular Basis for GABA
Sadeghi M; Carstens BB; Callaghan BP; Daniel JT; Tae HS; O'Donnell T; Castro J; Brierley SM; Adams DJ; Craik DJ; Clark RJ
ACS Chem Biol; 2018 Jun; 13(6):1577-1587. PubMed ID: 29746088
[TBL] [Abstract][Full Text] [Related]
36. Are alpha9alpha10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins?
Nevin ST; Clark RJ; Klimis H; Christie MJ; Craik DJ; Adams DJ
Mol Pharmacol; 2007 Dec; 72(6):1406-10. PubMed ID: 17804600
[TBL] [Abstract][Full Text] [Related]
37. Alpha-conotoxin Arenatus IB[V11L,V16D] [corrected] is a potent and selective antagonist at rat and human native alpha7 nicotinic acetylcholine receptors.
Innocent N; Livingstone PD; Hone A; Kimura A; Young T; Whiteaker P; McIntosh JM; Wonnacott S
J Pharmacol Exp Ther; 2008 Nov; 327(2):529-37. PubMed ID: 18664588
[TBL] [Abstract][Full Text] [Related]
38. Species specificity of rat and human α7 nicotinic acetylcholine receptors towards different classes of peptide and protein antagonists.
Yu J; Zhu X; Zhang L; Kudryavtsev D; Kasheverov I; Lei Y; Zhangsun D; Tsetlin V; Luo S
Neuropharmacology; 2018 Sep; 139():226-237. PubMed ID: 30025921
[TBL] [Abstract][Full Text] [Related]
39. Discovery and Structural and Functional Characterization of a Novel A-Superfamily Conotoxin Targeting α9α10 Nicotinic Acetylcholine Receptor.
Huang Q; Chu X; Zhang H; Yu S; Zhang L; Zhang X; Yu R; Guo C; Dai Q
ACS Chem Biol; 2022 Sep; 17(9):2483-2494. PubMed ID: 36048451
[TBL] [Abstract][Full Text] [Related]
40. Novel Three-Finger Neurotoxins from
Son L; Kryukova E; Ziganshin R; Andreeva T; Kudryavtsev D; Kasheverov I; Tsetlin V; Utkin Y
Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33672715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]